Global Partners Pledge $498.8 Million to Combat Rare Ebola Outbreak in Central and East Africa

African governments and international allies have committed nearly $498.8 million to combat the rapidly spreading outbreak of the rare Bundibugyo Ebola strain in Central and East Africa.

Jean Kaseya, head of the Africa Centres for Disease Control and Prevention (Africa CDC), announced the financial pledges following a high-level ministerial meeting dedicated to coordinating the continent's response. Kaseya noted that the funding highlights a strong sense of African solidarity and global cooperation, emphasizing that rapid intervention, regional coordination, and public trust are essential to containing the virus.

The urgency of the situation is heightened by the nature of the virus itself. The Bundibugyo ebolavirus is exceptionally rare and currently has no approved vaccine or specific treatment. Most existing Ebola therapeutics and vaccines were developed to combat the more common Zaire strain, which was responsible for the catastrophic West African epidemic between 2014 and 2016. Historically, the Bundibugyo strain has only caused two known outbreaks: one in Uganda in 2007 and another in the Democratic Republic of the Congo (DRC) in 2012.

World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus recently issued a stark warning that the epidemic is currently "outpacing" containment efforts. With the reported death toll now at 220, the WHO recently escalated the crisis by declaring it a Public Health Emergency of International Concern.

The $498.8 million pledge includes significant contributions from global entities. The World Bank is providing approximately $160 million specifically for the DRC's response, while the United States is contributing $82 million, and European partners are adding roughly $57 million. This follows a recent announcement by Tom Fletcher, the UN Under-Secretary-General for Humanitarian Affairs, who allocated $60 million from the UN’s emergency response fund to aid containment operations.

The outbreak continues to hit the DRC and Uganda the hardest. In the DRC, health authorities are tracking more than 900 suspected cases and over 100 confirmed infections, alongside hundreds of suspected deaths. Uganda has reported seven confirmed cases and one fatality so far, with health officials tracing several of these infections back to the initial cases.

Public health experts warn that until a targeted vaccine is developed, the current outbreak will remain a complex and highly challenging emergency to contain.